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KAJIAN IN VITRO DAN IN VIVO BUNGA Cassia surattensis TERHADAP 
Aspergillus niger 
 
ABSTRAK 
Penyakit berjangkit adalah salah satu masalah kesihatan yang paling lazim  
di negara membangun dengan peningkatan kerintangan antibiotik. Aspergilosis 
menjadi punca kematian yang tinggi dan kadar morbiditi di kalangan pesakit 
berimuniti rendah. Maka, terdapat keperluan segera untuk terapi antikulat baru bagi 
mengawal kadar kematian populasi. Pemilihan tumbuhan ubatan telah menjadi 
kecendurungan semasa di kalangan penyelidik sains kerana tumbuhan kaya dengan 
bahan bioaktif. Bunga C. surattensis dikaji untuk mengenalpasti organ ini sebagai 
suatu agen antikulat yang berpotensi. Saringan mikroorganisma patogen terpilih 
yang merangkumi Gram positif bakteria, Bacillus subtilis, Bacillus thuringiensis, 
Micrococcus sp dan Staphylococcus aureus, Gram negatif bakteria, Escherichia coli, 
Proteus mirabilis, Salmonella sp dan kulat, Candida albicans, Aspergillus niger dan 
Rhizopus sp Gram negatif dan kulat terhadap ekstrak bunga mendapati bunga ini 
memiliki sifat antimikrob. Zon perencatan untuk mikroorganisma daripada kaedah 
resapan cakera adalah dalam julat 13 ± 0.04 mm hingga 18 ± 0.00 mm. 
Mikroorganisma yang lemah terhadap ekstrak bunga seterusnya dinilai melalui 
Kepekatan Perencatan Minimum (MIC) untuk menentukan aktiviti ekstrak bunga 
terhadap mikroorganisma dalam cara yang bergantung pada dos. Nilai MIC bagi 
kedua-dua bakteria Gram positif dan Gram negatif adalah antara 3.125 mg/mL 
hingga 25.00 mg/mL. Bagi kulat, nilai MIC adalah antara 3.125 mg/mL hingga 6.25 
mg/mL. Ini diperhatikan melalui pemeriksaan ultrastruktur A. niger yang 
xxiii 
 
menunjukkan hifa yang terlipat, runtuh, terhimpit dan pecah. Konidiofor yang 
mengecut merupakan perubahan struktur utama yang dikesan pada konidia. 
Kehadiran agen antikulat dalam ekstrak bunga menyebabkan kerosakan kepada hifa 
dan konidiofor A. niger. Saringan kualitatif fitokimia ekstrak metanol bunga 
mendapati bahan karbohidrat, tanin, saponin, steroid, fenol dan flavonoid hadir 
sebagai sebatian aktif. Kajian ketoksikan menggunakan kaedah anak udang air 
marin dijalankan untuk menguji ketoksikan ekstrak bunga. Keputusan menunjukkan 
ketoksikan adalah negatif dengan  nilai LC50 3.32 mg/mL bagi ekstrak bunga dan 
LC50 0.27 mg/mL bagi kalium dikromat yang digunakan sebagai kawalan positif. 
Kajian ketoksikan akut oral dijalankan untuk menyokong keputusan ujian anak 
udang. Tikus yang menerima dos tunggal 5000 mg/mL ekstrak bunga tidak 
menunjukkan sebarang perubahan rekabentuk pada paru-paru, jantung, hati, limfa 
dan buah pinggang dalam pemeriksaan histopatologi dan mencadangkan ekstrak 
bunga sebagai tidak toksik. Aktiviti antikulat bunga C. surattensis terhadap A. niger 
diuji lebih lanjut dengan model sistemik aspergilosis. Tikus dijangkiti dengan 
konidia dikaji melalui penentuan beban keadaan spora, paras galaktomanan dan 
kajian histopatologi. Jumlah koloni dalam organ dan Indeks Galaktomanan (GMI) 
meningkat secara berterusan dalam kawalan negatif sepanjang kajian. Tikus dirawat 
dengan ekstrak bunga menunjukkan corak penurunan indeks GMI dan beban spora 
selepas hari ke tujuh walaupun saiz penurunan adalah lebih kecil berbanding tikus 
kawalan positif yang menerima Amfoterisin B. Keputusan ini disokong oleh kajian 
histologi yang mana bahagian tikus yang dirawat dengan ekstrak bunga memaparkan 
pemulihan daripada kecederaan tisu pada semua organ yang diperiksa berbanding 
kerosakan teruk yang diperhatikan pada kawalan negatif di akhir kajian. Pada hari 
terakhir jangkitan berkurangan dalam hati serta tiada pada paru-paru dan buah 
xxiv 
 
pinggang dalam kawalan positif. Kesimpulannya, bunga C. surattensis mempunyai 
potensi untuk dimajukan sebagai agent antikulat dalam bidang industri 
farmaseutikal.   
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IN VITRO AND IN VIVO STUDIES OF Cassia surattensis FLOWER 
AGAINST Aspergillus niger 
 
ABSTRACT 
Infectious disease is one of the commonest health problems in developing 
countries with the rise of antibiotic resistance. Invasive aspergillosis is causing high 
mortality and morbidity rate among immunosuppressed patients. Therefore, there is 
an urgent need for novel antifungal therapy to control the fatality rate in the 
population. Opting on medicinal plants has become the current trend amongst 
scientific investigators as plants are rich with biological activities. Cassia surattensis 
flower was studied to identify this organ as a potential antifungal agent. Screening of 
selected pathogenic microorganisms which were inclusive of Gram positive bacteria, 
Bacillus subtilis, Bacillus thuringiensis, Micrococcus sp and Staphylococcus aureus, 
Gram negative bacteria, Escherichia coli, Proteus mirabilis and Salmonella sp and 
fungi  Candida albicans, Aspergillus niger and Rhizopus sp against the flower 
extract revealed this flower to possess antimicrobial properties. The zone of 
inhibition for microorganisms from disc diffusion assay ranged from 13 ± 0.04 mm 
to 18 ± 0.00 mm. Microorganisms that were weak against the flower extract were 
further evaluated with Minimum Inhibitory Concentration (MIC) assay to determine 
the flower extract activity against the microorganisms in a dose dependent manner. 
MIC values for both Gram positive and Gram negative bacteria ranged from 3.125 
mg/mL to 25.00 mg/mL. For fungi, the MIC value ranged from 3.125 mg/mL to 
6.25 mg/mL. The presence of antifungal agent in the flower extract caused damage 
to the hyphae and conidiophores of A. niger. This was observed via ultrastructural 
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examinations on A. niger which demonstrated folded, collapsed, squashed and 
broken hyphae. Shrunken conidiospores were the major structural alteration detected 
on the conidia. Qualitative phytochemical screening of the methanolic flower extract 
found that carbohydrates, tannins, saponins, steroids, phenols and flavonoids were 
present as active compounds. Toxicity study via brine shrimp assay was performed 
to ensure the safety of the flower extract. Results turned out to be negative for 
toxicity with LC50 3.32 mg/mL for flower extract and LC50 0.27 mg/mL for 
potassium dichromate used as positive control. In vivo oral acute toxicity study was 
performed to support the nontoxic data. Mice administered with single dose of 5000 
mg/mL of the flower extract did not show any architectural alterations on the lung, 
heart, liver, spleen and kidney sections in the histopathology examinations and thus 
strongly suggested the flower extract as toxic free. Antifungal activity of C. 
surattensis flower against A. niger was further studied with systemic aspergillosis 
model. Mice succumbed with conidia was studied via organ fungal burden 
determination, galactomannan levels and histopathology analysis. Colony counts in 
the organs and Galactomannan Index (GMI) increased steadily in the negative 
control as the study prolonged. Mice treated with flower extract showed a reduction 
pattern in fungal burden and GMI after Day 7 onwards although the reduction size 
was smaller compared to the positive control mice which received Amphotericin B. 
This was supported with histological analysis whereby sections from the flower 
extract treated mice featured recovery of the injured tissue for all the examined 
organs compared to severe damage observed in the negative control by end of the 
study. By Day 28 conidia infection reduced in liver and was cleared from lung and 
kidney in positive control.  As a conclusion, C. surattensis flower could be a 
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promising candidate in the pharmaceutical industry for new antifungal drug 
discovery using plant as the main ingredient.  
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CHAPTER ONE 
 
GENERAL INTRODUCTION 
 
 
          Million years back, oceans conquered the earth but evolution has totally 
formed an unexpected scenario today. Besides Homo sapiens, other living and non-
living organisms have crammed the world today. History stated the existence of all 
living creatures on this planet at present primarily diverged from the earliest 
organism recognized as bacteria. At present, different types of diseases have born 
together with the growing world. Apparently, diseases can be caused by internal or 
external factors. Internal factors refer to diseases caused due to autoimmune 
condition. Autoimmune diseases result from the attack of immune system in human 
body against its own tissues and cells in the body. There are nearly 70 different 
autoimmune disorders. Cancer, diabetes mellitus and cardiovascular diseases are 
some of the classified autoimmune diseases (Lleo et al., 2010). Meanwhile, 
infectious organisms are the dominant external factors leading to infectious diseases. 
The pathogenic microbial agents include bacteria, fungi, viruses, parasites, protozoa 
and prions (Roche and Guegan, 2011).   
 
Although the age of disease is as old as human species its implications on 
man’s shelf life are stable. Infectious diseases were treated with the discovery of 
antibiotic substance the penicillin by Alaxender Fleming in the earlier days, thus 
keeping the diseases in control and significantly increased the survival rate. 
Unfortunately, with the parallel usage of antibiotics the microorganism resistance 
towards antimicrobial agents has emerged tremendously (Seyyednejad and 
Motamedi, 2010). Variation and diversity of genetic elements in the microorganisms 
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over the years could best explain the reason for resistance against available 
commercial drugs over the years. 
 
          Usually, outbreaks of infectious diseases such as Severe Acute Respiratory 
Syndrome (SARS), influenza flu, hand, foot and mouth disease, hepatitis and human 
immunodeficiency virus (HIV) are the commonly known by public (Zhang et al., 
2011). These epidemic diseases causes sudden panic in the society as people become 
aware of the consequences from the outbreak. However, there are very few or 
limited people who recognize diseases such as aspergillosis, candidiasis, 
histoplasmosis, cryptococcosis or salmonellosis although these are also classified as 
infectious diseases (Saag et al., 2000; Rex et al., 2000).  Mycological infections 
have emerged as an important cause of morbidity and death amongst critically ill 
patients (Meersseman et al., 2004). Fungal infection is a result of fungal invasion 
into human body at a distinct location and leads to deteriotion of human health. 
There are different types of fungal infections such as superficial mycoses, cutaneous 
mycoses, subcutaneous mycoses, systemic mycoses, opportunistic mycoses and non-
opportunistic mycoses (Hean et al., 2011). Infections caused by opportunistic fungi 
are classified as new spectrum of fungal pathogens as they were earlier recognized 
as plant pathogens and now causing disease in human beings (Singh, 2001).   
           
Aspergillus sp is the main agent causing aspergillosis, a type of opportunistic 
fungal infection (Alexander, 2002). Aspergillus niger is identified as one of the 
primary causative agents to Invasive Aspergillosis (IA) from the genus Aspergillus 
(Taylor et al., 2009).  Although recognized as notorious pathogenic fungi, A. niger is 
classified as an important class of organism in the biotechnology industry. This 
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filamentous fungus is used to produce a variety of products and chemicals which 
represent billions of dollars in annual sales (Kim et al., 2007). The escalating 
incidence of coupled to the staggering overall case fatality ratio in excess of 50% 
indicating that our therapeutic outcomes are suboptimal (Lin et al., 2001). Varieties 
of antifungal drugs are available but limit to resistance or causing toxicity and side 
effects. Available treatments fail to complement with IA, thus urging scientists to 
opt for new sources for drug inventory.  
  
Aspergillosis involves both infection and growth of fungus as well as allergic 
responses (Hean et al., 2011). Aspergillosis develops as a result of inhalation of 
Aspergillus spores. Aspergillus sp is an opportunistic pathogen which affects 
cavities that have formed in lungs from preexisting lung diseases. Ideally, aspergilli 
form tangled mass of fungus fibers. The fungal mass enlarges gradually and destroys 
the lung tissue in the process, but usually does not spread to other areas unless under 
certain circumstances (Bansod and Rai, 2008). IA dominates in patients with 
neutrophil abnormalities or in immunocompromised patients. For example, patients 
who have or are receiving intensive treatments for haematological malignancies 
such as remission-induction chemotherapy and haematopietic stem cell 
transplantation, with advanced AIDS or chronic granulomatous disease have greater 
risk for this opportunistic disease (Neofytos et al., 2009).  
 
          Living in a prebiotic era does not stop us from turning back to traditional 
prescriptions to treat any types of illness when the role of modern medicines is 
becoming mild. The use of plants is most accepted compared to those derived from 
animal source for some religious reasons in some communities. Today, 
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‘Ethnopharmacology’ has become an open access platform for bioscientific and 
clinical research on medicinal and food plants used throughout the world. This 
multidisciplinary approach is an essential basis for exploitation of the plant 
resources as tomorrow’s medicine. Until today some of the neglected diseases such 
as diarrhea and tuberculosis are treated with herbal medicines (Heinrich, 2010). 
           
The term phytomedicine was born after the ‘marriage’ of phytochemical and 
medicine. Phytomedicines have become the major component of traditional system 
of healing in almost all developing countries and used as drugs for millennia 
(Briskin, 2000). Most of current research on phytochemical investigations is devoted 
to higher plants which are associated with ethnobotanical information. With respect 
to the current tendency for discovering a new antimicrobial agent from natural 
resources, the native plants from any region can become a good choice for research 
and for mass production of natural antibiotics. Surely this is the right time to address 
the fast-approaching population crunch with the currently available advanced 
technology.  
        
Malaysia is well known for an astonishing biodiversity amongst other Asian 
countries. It has a tropical climate with fertile lands that provide a healthy growth of 
flora. Plants are considered as an important asset to mankind not only for therapeutic 
reasons but for providing shelter and protection in the earlier days. Natural resources 
from tropical rainforests have literally become the life-support system to man since 
ancient times (Gupta et al., 2005; Ahsan et al., 2009). In the last few decades plants 
have been the important essence for chemists and biotechnologists. Most of the 
prescribed drugs around the world are derived directly from plants. Hence, the latter 
5 
 
are called medicinal plants as the naturally developed secondary metabolites are 
used to design drugs. There is very limited literature on the potential bioactivity of 
Cassia surattensis plant especially on the flowers. Thus, this plant was chosen to 
evaluate the potential activity of the flowers in warding off infectious diseases 
caused by pathogenic microorganisms. 
 
 
 
1.1   OBJECTIVE 
 
 
This study was carried out to achieve the following aims:  
 
 
(a) To evaluate the antimicrobial activity of Cassia surattensis flower against 
pathogenic microoorganism  
 
(b) To study the effects of C. surattensis flower extract on the morphology of 
Aspergillus niger   
 
(c) To screen the  phytochemical constituents in the methanol extract of Cassia 
surattensis flower extract 
 
(d) To study the toxicity effect of Cassia surattensis flower extract  
 
(e) To evaluate in vivo antifungal activity of Cassia surattensis flower extract 
against Aspergillus niger  
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CHAPTER TWO 
 
LITERATURE REVIEW  
 
 
2.1       History on use of Plants as Medicine  
 
Recognition on potential health promoting ingredient in plants was traced in 
the earliest recorded history. The power of plants was explored by the Indians, 
Chinese, Egyptians, Greeks, Romans and Syrians about 5000 years back from the 
evidence of ancient records. About 500 plants with medicinal use are mentioned in 
ancient text and used in indigenous medical system. Up to date, various indigenous 
systems such as Ayurveda, Siddha and Allopathy use different kinds of plant species 
to treat many types of diseases (Samy and Gopalakrishnakone, 2007). Over the 
centuries, plants have become a source of food and medicine for man. The use of 
herbal remedies has become deeply rooted in the folkoric culture. These beliefs and 
attitudes have accounted for a brighter modern medical treatment these days. 
Hipocrates once said ‘thy food shall be thy remedy’ and today it has become a fact. 
 
 
2.1.1    Natural resource: Plants as target   
 
Natural resources particularly plants have always persisted as the first target 
for many purposes especially in drug discovery when the synthetics fail to function 
effectively. Flora has strong connections with man and it is a gift from God that 
perishes the globe. The extensive use of herbal remedies and medicinal plants are 
clearly described in holy texts such as the Bible and Vedas. Thus, various plants are 
used for therapeutic effect for years in daily living to treat diseases all over the 
world (Nair et al., 2005). Current researches on natural molecules and products 
primarily focus on plants since they can be sourced more easily and selected on 
basis of their ethno-medicinal use (Verpoorte et al., 2005). Traditional knowledge 
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provides a better and enhances the probability success in pharmaceutical industry 
since individual mass screening of plants is vastly expensive, inefficient and time 
consuming. Vascular plants such as angiosperms, gymnosperms, conifers, ferns and 
clubmosses are the common identified classes of medicinal plants.   
 
           In the current scenario, almost throughout the globe medicinal plants are 
playing the superior role in health care due to the vast biodiversity and side effects 
caused by synthetic drugs. Out of the total 422,000 flowering plants reported from 
the world, more than 50,000 are used for medicinal purposes (Poonam and Singh, 
2009). The revival interest in herbal remedies especially using plants is due to the 
presence of active constituents in this resource. Plant develops secondary 
compounds consisting of biochemical compounds with active molecular structures 
which benefit in the findings of lead compounds for synthetic field. Moreover, most 
of the modern drugs molecular structures were designed using the chemical 
structures of the active principles as reference.  
 
          Plants always receive more attention due to the lower incidence of adverse 
reactions to plant based products compared to synthetics. This encourages the 
nations to consider plant as a new source for medicines as an alternative to modern 
medicines. Thus, the academia researches are diverting their work towards natural 
resources particularly plants to discover new drugs in order to control the toxicity 
and mortality caused by current medicines. Edible medicinal plants receive more 
attention as they are rich with variety of minerals, vitamins and practiced very often 
in daily living (Ramos et al., 1995). Apart from using medicinal plants in primary 
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health care system they were also the alternate sources of income for the 
unprivileged communities (Bussmann et al., 2007). 
 
2.1.2    Phytomedicines from plants 
Naturally, the use of medicinal plants would have never existed throughout 
ages if not for the observed pharmacological actions on subjected diseases. While 
plants are widely practiced as a therapeutic source for years, single compound 
therapy has dominated in the pharmaceutical industries. The evolving medicines 
from these compounds are recognized as phytomedicines in health care system 
(Ekstein and Schachter, 2010). Natural products are promising candidates for drug 
discovery and will still continue to play an important role in future drug 
development (Newman and Cragg, 2007). About 25% of drugs in modern 
pharmacopoeia were derived from plants whilst many others were synthetics 
mimicked from plants isolated compounds (Rao et al., 2004). Triptolide, celastrol, 
artemisinin and capsaicin are some of the promising phytomedicines in the 
pharmaceutical industry (Heinrich, 2008). Besides, many others have been marketed 
and actively used as shown in Table 2.1.  
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 Table 2:1 Plant derived phytomedicines  
Plant Drug Biomedicine use Reference 
Adhatoda vasica vasicin antiplasmodic, cough suppresion Gurib-Fakim, 2006 
Allanblackia monticola lupeol arthritis, diabetic Siddique and Saleem, 2011 
Cannabis sativa nabilone, dranabinol sclerosis, epilepsy, glaucoma Amar, 2006 
Cathranthus rosesus vinblastine, vincristine leukimia, lymphomas Aslam et al., 2009 
Condrodendron tomentosum D-tubocurarine muscular relaxation Gurib-Fakim, 2006 
Curcuma longa curcumin hepatoprotective Srivastava et al., 2011 
Gingko biloba ginkgolides dementia, cerebral deficiencies Beek and Montoro, 2009 
Harpagophytum procumbens harpagoside rheumatism, kidney inflammation Stewart and Cole, 2005 
Mentha piperita menthol analgesic, digestive disorder Galeotti et al., 2002 
Panax ginseng ginseng anemia, hypertension Wang and Ma, 2006; Choi,2008 
Prunus agricana sitosterol prostate hyperplasia Stewart, 2003 
Taxus baccata taxol ovarian cancer,  Malik et al., 2011  
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2.1.3    Drug discovery: Current scenario   
 
Pharmaceutical industries were amongst the rich sectors making pennies ever 
since the world moved on with globalization. The credit for the incredible growth in 
this industry is primarily due to the discovery of blockbluster drugs inventory with 
advent of modern technology assistance (Patwardhan and Vaidya, 2010). Generally, 
the process of drug discovery is time consuming and arduous as it begins from the 
stage of drug design, identifying potential clinical candidates for the drug and finally 
introducing into the market. Sometimes it spans the course of more than a decade 
and the expenses could exceed to 800 million USD in United States of America 
(Schmid and Smith, 2006). Approval from the Food and Drug Administrations 
(FDA) remains as regulatory before a modern drug receives the commercial 
licensing. However, at present the trend suggests a decline in the market for the new 
drugs and it is no longer the economic growth asset. As stated by Hughes (2008) the 
number of new drugs approval declines to 17 in the 21st century compared to 53 in 
the year 1996. Hence, the industry is facing tremendous crisis that can progressively 
worsen if the current situation is not well managed.   
 
Over this background, the pharmaceutical industry is giving attention to 
experiential wisdom and holistic approach to offer new potential drugs that are safer 
and more effective. Natural products are believed to perform various functions and 
most possess interesting and useful biological activities (Philip et al., 2009). Thus, 
ethnopharmacology, traditional and complementary medicines were focused as new 
strategic options (Patwardhan and Mashalkar, 2009). In fact, over 50% of all the 
modern clinical drugs are derived from natural product origin that plays role in drug 
development programs in pharmaceutical industry (Nair et al., 2005). Since 
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traditional medicines are notified for the affordable health remedies for therapeutic 
reasons, thus the current interests on medicinal plants are growing worldwide.  
 
 
2.2        Cassia spp  
 
Cassia is a family of Caesalpiniaceae or Leguminosae in the subfamily 
Caesalpinioideae comprising about 600 species (Panda et al., 2010) among which 
are from delicate, annual herbs to highly attractive tall flowering trees present 
mostly in the tropics and subtropics (Tripathi and Goswami, 2011). Cassia spp 
tolerates a wide range of climates and temperatures, though it prefers warm 
condition. Within its bounds Cassia spp may be seen with great diversity in habit, 
ranging from tall trees to delicate, prostrate and annual herbs (Irwin and Turner, 
1960). Cassia spp are also used as favourite food plants by the caterpillars.   
 
 
2.2.1     Cassia surattensis  
 
Cassia surattensis is an impressive small flowering tree and commonly 
planted as a street and landscape tree whereby it makes a nice dooryard or entrance 
gate welcoming plant. C. surattensis is native in Australia and to most of Asian 
countries like India, Thailand, Vietnam, Indonesia, Malaysia, Laos, Ceylon, 
Polynesia and the Philippine islands (El-Sawi and Sleem, 2010). In Malaysia this 
plant is easily seen along the roadside and being recognized as ‘bushy cassia’ (Chew 
et al., 2009). Locally, this flowering plant is known as ‘Kembang Kuning’ or 
‘Kassia Gelenggang’. The beautiful bright yellow flower blooms in cycles year-
round. In Thailand this plant is known as Kalamona Tree or ‘magic’ tree because the 
Thai’s believe that the plant offers security and fulfill wishes, goals and hopes.   
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2.2.2    Taxanomy of Cassia surattensis  
 
 
Scientific classification of Cassia surattensis is as follows: 
 
Kingdom     : Plantae   
Division      : Magnoliophyta 
Class           : Magnoliopsida 
Order          : Fabales 
Famili         : Caesalpiniaceae alt Leguminoseae 
Subfamily   : Caesalpinioideae  
Tribe           : Cassieae 
Subtribe      : Cassinae 
Genus         : Cassia 
Species       : C. surattensis  
 
Synonmous name: Cassia suffruticosa, Cassia glauca., Senna surattensis, Cassia  
                                 fastgiata  
 
Local Common names: Kembang Kuning, Busshy Cassia, Scrambled egg bush,   
                                         Glaucous Cassia, Golden Senna   
 
Other Common names: Singapore Shower, Sunshine Tree, Sulphur-flowered senna  
(Anonmyous, 2011)  
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2.2.2.1 Plant morphology and characteristics  
 
External features are normally important to identify and differentiate plant 
species from its genus. Cassia surattensis (Plate 2.4) is one of the few Cassias likely 
to grow in a shrub form up to 7 m tall with many branches. The dark green leaves 
are bipinnate, each bearing 14-18 oblong leaflets measuring 25 mm long and 12 mm 
broad (Chew et al., 2009). Its clusters of yellow blooms are present with 10 stamens 
1-1 ½ inches wide in semi-erect panicles. C. surattensis bears fruits called pods 
which are normally flat, papery and measures to about 7 inches long. This plant is 
drought tolerant once established and is a rapidly easy growing shrub.  
 
 
 
 
 
 
Plate 2.1 Cassia surattensis  
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2.2.2.2 Traditional uses  
 
In Chinese tradition, the leaves are boiled and the infusion is consumed as a 
medicine to treat constipation, cough and sore throat (Chew et al., 2009). C. 
surattensis leaves are practiced in both internal and external cooling medicine in 
Balinese community (Sangetha et al., 2008). In folk medicine, C. surattensis bark 
and leaves are used for treatment of fungal skin diseases, diabetes and gonorrhea 
(Gritsanapan and Nualkaew, 2001; Petchi et al., 2012). Roots of this plant are 
blended, filtered and consumed orally as juice to heal snake bites in Purandhar 
region of Maharashtra, India. 
 
 
  
2.2.2.3 Pharmacological activities  
 
Plants are classified as medicinal plants when they are detected with 
biological activities. Cassia surattensis is generally recognized as a medicinal, 
ornamental and economically important plant (Vajpayee et al., 2000) as other 
Cassias. Leaves of this plant were also found to be antihyperlipidemic when tested 
against hyperlipidemic rats (El-Sawi and Sleem, 2009). The bright golden yellow 
flowers are also found to be a good antioxidant (Chew et al., 2011).  
 
Various pharmacological properties such as antioxidant, anti-inflammatory, 
antidepressant, muscle relaxant and many others are possible with the presence of 
different types of phosphodiesterase inhibitors (PDEIs). PDEIs are seen as potential 
agents for therapeutic reasons which will be helpful for diseases like asthma, 
depression, schizophrenia and congestive heart failure. Studies found C. surattensis 
as one of the potential herbal phosphodiesterase inhibitors (Rahimi et al., 2010).   
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2.2.2.4 Phytochemical studies 
Phytochemicals are chemical compounds developed naturally in plants 
allowing the latter to possess medicinal properties. Up to date, there is limited 
literature on the phytochemistry of C. surattensis plant.   
 
Flavonoids a large group of polyphenolic compounds was detected in the 
leaves of C. surattensis plant (Rahimi et al., 2010). Phytochemical analysis on the 
flavonoids revealed the presence of quercetin, rutin and quercetin-3-O-glucoside 7-
O-rahmnoside. These compounds are reported to inhibit xanthine oxidase, protein 
kinase C and phosphodiestearases. Quercetin help to inhibit lipid peroxidation by 
blocking xanthine oxidase enzyme, chelating iron, scavenging hydroxyl, peroxy and 
superoxide radicals which reveals its antioxidant property. This compound helps to 
inhibit structural damage to protein (Salvi et al., 2001) and protects the oxidative 
products generated by the respiratory burst in phagocytes (Zielinska et al., 2000).  
 
          Another study revealed the presence of unsaturated fatty acids, sterols, phytols 
and squalene in C. surattensis leaves which are responsible for improvement on 
hyperlipidemic. Phytol, the common terpenoid esterified to chlorophyll to confer 
lipid solubility is valuable in controlling lipid abnormalities in diseases like obesity 
and diabetes (El-sawi and Sleem, 2009; Schluter et al., 2002). Squalene, an 
isoprenoid intermediate of cholesterol biosynthesis obtained from diet was found to 
reduce serum triglyceride and cholesterol levels in humans (Simonen et al., 2007). 
Anthraquinone also a compound that was detected in the leaves is generally used as 
laxatives mainly from their glycosidic derivatives (Gritsanapan and Nualkaew, 
2001).  
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2.3     Antimicrobial nature 
 
          Microorganisms are indispensable components in our ecosystem. Their 
contribution on this globe is greater than human. These organisms benefit the 
society in many aspects such as in food industries, health care and agriculture. The 
role of microorganisms in the environment becomes transparent as they are always 
pointed for the reasons of many types of diseases. Even though they are always 
recognized as the smallest living organisms, their capabilities are unchallengeable to 
those of humans. Infections by these nano creatures can lead to severe disease 
conditions especially in immunosuppresed patients. In addition, infectious diseases 
caused by microorganisms remain as a major threat to public health particularly in 
developing countries due to lack of medical facilities plus emergence of drug 
resistance (Okeke et al., 2005).   
 
          At the current state, the commercially available antibiotics are losing their 
potentials and capabilities to control the colonization of microbes in human host. 
Efforts to identify and develop new antibiotics are actively practiced by researchers 
in every part of the world in order to reduce the incidence of opportunistic diseases. 
Developing a novel drug involves many procedures and regulations. Initially, the 
potential drug source is targeted and antimicrobial assays are performed to screen 
the activity against microorganisms. The drug is than tested on animal models 
followed by clinical trials before it is being commercialized.  
 
 
 
 
 
17 
 
2.3.1 Antibacterial and antifungal assays  
 
  
The validation of antimicrobial activity exhibited by crude extracts from 
promising antimicrobial source can be evaluated based on the growth response from 
the tested microorganism. In the test, microorganism has direct contact with the 
sample and percentage inhibition reflects the potency of the sample as an antibiotic. 
There are many assays that can be used in an antimicrobial study but the common 
classical methods are still being applied up to date as they are sensitive to the tested 
materials. The common in vitro antibacterial and antifungal test methods 
implemented in almost all antimicrobial studies are the diffusion and dilution 
methods. 
 
2.3.1.1 Agar  diffusion method  
This test involves the use of solid medium; agar and filter paper disc. The 
streaked inoculum becomes contact with the sample and forms a clear zone called 
zone of inhibition (inhibition diameter) as a result of exhibiting antimicrobial 
activity. A larger zone indicates a greater chance of the sample as an antibiotic agent. 
In this technique, the specific advantages are that only a small sample is required 
and can be tested up to six extracts per plate against a single culture (Hadacek and 
Greger, 2000). In agar diffusion test, the sample basically diffuses into the agar and 
inhibits the growth of the tested microorganism when it penetrates to obtain food 
from the medium for survival. Thus, this method is not suitable for testing non-polar 
samples as the latter cannot diffuse into the agar. Sometimes, the inoculated plates 
are kept at a lower temperature for several hours before incubation to favour the 
compound diffusion over microbial growth, thereby increasing the diameter of clear 
zone (Cos et al., 2006).    
18 
 
2.3.1.2 Broth dilution method 
Broth dilution uses liquid medium to measure the growth of microorganisms 
inoculated into dilution series of antimicrobial agents. It is a commonly used method 
to determine the minimum inhibitory concentration (MIC) of antimicrobial agents 
that will kill (bactericidal or fungicidal) or inhibit the growth (bacteriostatic or 
fungistatic) of bacteria or fungi. The presence of turbidity or sediment indicates 
growth of the microorganism (Wiegand et al., 2008). MIC value is determined as the 
lowest concentration of the antimicrobial agent that prevents visible growth of a 
microorganism under defined conditions (Gabrielson et al., 2002). MIC 
determination can be used for monitoring the development of antibiotic drug 
resistance (Kahlmeter et al., 2003). There are two variations of broth dilution 
method which are macrodilution and microdilution. If the final volume of the test is 
2 mL or more it is termed macrodilution. Microdilution is performed in microtiter 
plates using volume of ≤ 500 µL per well (Wiegand et al., 2008).   
 
2.3.1.3 Inhibition radial growth  assay 
Filamentous fungi do not grow as single cells, thus a better challenging 
standardization method is required than unicellular organism like bacteria and yeast. 
Besides agar disc diffusion and broth dilution methods for determining antifungal 
activity, the inhibition radial growth assay can be another useful tool to measure the 
sensitivity of filamentous fungi to antifungal compounds (Slawecki et al., 2002). 
The assay uses agar medium where the growth on the media is superficial. Mycelial 
plugs excised from the edges of actively growing colonies are inoculated on the 
Petri plates with antifungal compound (Engelmeir and Hadacek, 2006). Growth on 
the solid media has one advantage over the liquid medium. In liquid medium, the 
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submerged hyphal growth takes place under low oxygen concentrations but fungi 
growing on agar surfaces are less subjected to this constrain (Hadacek and Greger, 
2000). The inhibition effect is determined by measuring the colony diameters in 
Petri plates.   
 
Radial growth assay was found to be economical, easy to perform and 
require minimal laboratory equipment. Thus, this technique can be used for a large 
scale sample screening for antifungal agents. Due to its ease of operation, it can 
provide fast and effective screening method for the discovery of new types of 
antifungal agents in future (Liu et al., 2002). However, the drawback of this 
technique is addition of antifungal compounds in the agar medium whereby if the 
media is hot the compounds can be denatured resulting in poor outcome. 
 
 
2.3.2 Specific conditions for antibacterial and antifungal screenings   
2.3.2.1 Panel for test organisms  
To ensure a good outcome in antimicrobial activity screening with new 
sample, variety of strains should be subjected to this test. The choice of test 
organisms should consist of Gram positive bacteria, Gram negative bacteria and 
fungi. Cultures like Candida albicans, Aspergillus niger, Rhizopus stolonifer and 
Fusarium solani are common fungal strains used in antimicrobial study.  
 
2.3.2.2 Growth medium   
Appropriate media is important for microorganism growth in antimicrobial 
study. Mueller-Hinton Agar (MHA) or Mueller-Hinton Broth (MHB) and Nutrient 
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Agar (NA) or Nutrient Broth (NB) are the common growth media for bacteria, while 
Sabouraud Dextrose Agar (SDA) or Sabouraud Dextrose Broth (SDB) and Potato 
Dextrose Agar (PDA) or Potato Dextrose Broth (PDB) are for fungi. The enrichment 
component in each of this medium differs according to the preference of microbes. 
The slight differences in the composition of the growth medium can influence the 
antimicrobial activity of a compound (Butaye et al., 2000). The choice of medium 
used has to meet the requirements of National Committee for Clinical Laboratory 
Standards (NCCLS) which is recommended as the reference medium for agar and 
broth dilution assays (Anonmyous, 2000). 
 
 
2.3.2.3 Inoculum  
 
Standardization of the inoculum size is important to prevent influence on the 
potency antimicrobial activity of the sample. In disc diffusion test, only a single 
colony is used to streak the plate to avoid overgrowth of the culture on the plate. The 
inoculum size used in dilution methods are 105 CFU/mL for bacteria and 103  to 104 
CFU/mL for yeast and fungi (Hadacek and Greger, 2000). Generally, too low 
inoculums size will lead to many false- positive results and too high inoculums size 
increase the chances of false-negative (Anonmyous, 2003).  
 
2.4       Toxicity  
Drug resistances or side effects like toxicity are the common hitch of many 
medicines. New drug discovery brings excitement especially if it is affordable by 
everyone. Keeping the healing properties in mind safety measures to ensure the drug 
is non-toxic remains a major precaution. In laboratory conditions, toxicity can be 
evaluated in terms of in vitro and in vivo. Generally, for in vitro study, brine shrimp 
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lethality test remains as the simplest and economical probe. Further toxicity study is 
conducted with animal models for in vivo study. Toxicity studies allow us to 
understand the symptom, mechanism, treatment and poisoning effect of the material. 
Toxicology data can also provide a better chance for a new drug formulation in the 
pharmaceutical industry (Sasidharan et al., 2010).  
 
2.4.1    Brine shrimp assay  
Brine shrimp or Artemia salina is an invertebrate found in sea-water and 
other saline ecosystems (Bussmann et al., 2011). This method was developed by 
Meyer in 1982 to monitor the biological response of A. salina against a test sample. 
Artemia is frequently used agent in laboratory assays to determine the toxicity 
values by estimating LC50 (median lethal concentration) (Coe et al., 2010). The 
lethality can be determined based on the mortality of the brine shrimps. Toxicology 
is pharmacology at higher doses, thus findings of lower or non-toxic activity might 
be very useful in the pharmacology and physiological systems (Montanker et al., 
2002).  
 
2.4.2    Oral acute toxicity  
Acute toxicity refers to the adverse effects that occur on first exposure to a 
single dose of substance. At in vivo level animal models like mice and rats are 
common used in experiments to evaluate the toxicity level. Acute systemic toxicity 
is assessed by administration of a single dose of compound orally, dermally or by 
inhalation. The aim of the study is for pharmaceutical reasons, as results from the 
animal test are used for deriving potential new medicines. In this context, the 
toxicity data provides information whether the drug outweigh any health risks like 
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adverse side effects and to establish safe drug dosage. This study is normally carried 
out according to the Organization of Economic Cooperation and Development 
(OECD) 420 (2001).  
 
 
2.5       Tools for Fungal Diseases Diagnosis 
 
Poor treatment facilities and delayed diagnosis are some of the reasons for 
the rise of fungal infectious diseases observed in developing countries. An accurate 
diagnosis of aspergillosis is important as early diagnosis has been associated with 
improved survival rate among patients. Currently, with advance technology there are 
many alternative tools for pathologist in an effort to decrease the statistics of fungal 
infections. Leaving the computed tomography (CT) scanning there are other 
effective models for diagnosing invasive aspergillosis (Ellis, 2002).  
 
 
2.5.1     Histochemistry  
 
This technique has the potential to depict the colonized fungal species on 
screened tissues. Visualization of the hyphae and spores of the fungi helps to 
determine the degree of infections and the invaded area in the particular tissue.  
 
2.5.1.1 Fungal stains  
 
Use of specific fungal stains can be considered as a possible diagnostic for 
fungal infections like aspergillosis (Denning et al., 2003). Besides, haematoxylin 
and eosin special fungal stains such as Gomori’s Methenamine Silver (GMS) can be 
applied on the histological sections whereby GMS helps to stain the fungal elements. 
Therefore, GMS stain acts as a sensitive stain to detect any small fungal fragments 
in the infected host tissue (Hope et al., 2005).  
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2.5.2     Serological technique  
 
2.5.2.1 Galactomannan assay  
 
Galactomannan determination is becoming another important early 
diagnostic means. This test is performed using the commercial assays for 
galactomannan detection which is known as Platelia Enzyme linked immunosorbent 
assay (ELISA) (BioRad, Marnes-La-Coquette, France) (Ascioglu et al., 2002). 
Galactomannan is a component in the fungal cell wall of most Aspergillus and 
Penicillium species. Generally, serum samples and bronchoalveolar lavage fluid 
(BAL) are subjected to galactomannan assay. Nevertheless, galactomannan was also 
found to be present in other body fluids including cerebral spinal fluid (CSF), 
peritoneal fluid, pericardial fluid and urine (Klont et al., 2004). This technique uses 
the antibody-antigen binding principle whereby the monoclonal antibody from rat 
EB-A2 binds with the β (1-5)-linked galactofuranoside side chain residue of 
galactomannan molecule. The detection uses sandwich ELISA concept. Optical 
density (OD) obtained from this assay confirms the diagnosis of aspergillosis and 
the degree of infection (Maertens et al., 2001). 
 
2.5.2.2 Other techniques  
Polymerase chain reaction (PCR) using nucleic acids can also be used for 
diagnosis of aspergillosis. However, lack of standardization on the technical issues 
remains as a barrier to use this application as a diagnostic model (Bretagne, 2003). 
Aspergillus species are widely used in food industries due to the production of 
secondary metabolites. Hence, metabolites were found to be another diagnostic tool. 
Unfortunately, the complexity of measurements that requires gas liquid 
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chromatography and mass spectroscopy becomes a major concern and the technique 
is less preferred (Lewis et al., 2005). 
 
 
2.6       Fungi  
 
Fungi fall in the group of microorganisms and are represented by a large 
number of species. Their ubiquitous distribution in the biosphere, longevity and 
ability to survive in a wide range of environmental conditions has made fungi the 
most successful group of organisms. Fungi are heterotrophic organisms whereby 
they are dependent on dead or living organisms for their growth. This organism 
comprises approximately 25% of the global biomass (Eduard, 2009). Since ancient 
days, fungi are present as both saprobes and parasites. Fungi are recognized as 
decomposer agents as thay are able to degrade complex organic materials to a 
simpler compound in the environment. By this way, critical constituents such as 
nitrogen, carbon and phosphorus are released to the atmosphere for the survival of 
organisms.   
 
Fungi, especially those which are filamentous are used in biotechnological 
processes due to their metabolic versatility and capability for secreting enzymes, 
proteins and other important industrial metabolites (Papagianni, 2004). Thus, they 
remain as an important research tool for biotechnologists and microbiologists in 
biological processes. On the contrary, fungi have many negative aspects in that they 
cause major diseases in plants and animals. The ability of these fungi to release 
chemical substances like mycotoxins in foods and invading human cells causing 
infectious diseases have inspired fear and superstition in man. However, not all 
fungi are harmful to man as some are considered as safe. 
25 
 
2.6.1    Species characteristics 
 
Like bacteria, fungi have their own subgroup of organisms namely 
mushrooms, moulds and yeasts. Classification of fungi depends upon morphological 
characteristics, reproduction structures and growth conditions. Each species bears 
different characteristics and is grouped in different genera. Genomics approach is 
used to identify and classify some fungi when the traditional identification approach 
not sufficient (Eduard, 2009). 
 
2.6.2    Biological and physical properties  
Fungi are eukaryotic organisms and monopoly on other dead or living 
material for survival. Fungi are dependent on oxygen, water and organic materials 
for growth whereby oxygen and organic materials are readily available in the 
environment but access to water sometimes remains the limiting factor. However, 
water content of about 12-15% in materials is usually sufficient to sustain fungal 
growth as some fungi are capable of growing in lower water content when the 
relative humidity in the air is above 85% (Green et al., 2005). The growth of fungi is 
also dependable upon other conditions like temperature. Most fungi are classified as 
mesophillic because they grow at 15-30°C. In contrast, Cladosporium herbarum is 
able to grow below 5°C and is known as psychrotolerant species. Aspergillus 
fumigatus and Aspergillus niger have an optimum growth close to human body 
temperature which allows these species to invade the human cells and cause 
opportunistic diseases (Eduard, 2009).  
 
 
 
